MAPT and dementia: The aim of this review is to gather and summarize studies conducted to date, on using selected proteins that can act as dementia biomarkers in blood material, for example, Aβ40 and Aβ42 amyloids, tau protein, as well as its phosphorylation products (p-tau) and YKL-40 protein.